Common questions about COVID-19 vaccination answered

Quick answers to some key questions you may be asked about the COVID-19 vaccination, based on information from the Green Book.

Like

This article provides quick answers to common questions patients may ask about the COVID-19 vaccination. 

This summary is based on the information in COVID-19: the green book, chapter 14a and focuses on the Pfizer BioNTech COVID-19 vaccine, approved on 02 December, and the Oxford–AstraZeneca COVID-19 vaccine, which is undergoing phase 3 trials.

Common questions about COVID-19 vaccination

  • Doctor I have a bleeding disorder, should I be concerned?
  • What should be done if a patient’s vaccination course is interrupted?
  • Is a booster dose required after the two doses?
  • Can I have the COVID-19 vaccine with other vaccines?
  • Is the vaccine safe in pregnancy or when breastfeeding?
  • Is the vaccine safe in children?
  • Is the vaccine safe in those with immunosuppression or HIV?
  • What are the contraindications to use of the vaccine?
  • What happens if the patient has a minor illness?
  • What adverse events should patients be warned about?
  • Is there any reported anaphylaxis or other allergic reactions?
  • Can vaccination be used if a patient exposed to COVID-19?

To view full article register to OnMedica and then click
'View full content'. 

    


For a comparison of the key characteristics of each vaccine, you can also access our practical reference table, which you can download:

OnMedica

Editorial team, Wilmington Healthcare

OnMedica provides high-quality, easy to digest content and CPD for UK-based GPs and clinicians. Our team of expert editors and clinicians develops content across a wide range of topics in a variety of formats—expert articles, bitesize news and quizzes, courses, videos, and more. You can explore OnMedica via the homepage, drop down menu or by typing your topic of choice in the search bar. Why not find out how OnMedica can help you to keep up to date quickly and easily?
3661 Contributions
194 Followers
1 Following
Comments are disabled